FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Vismodegib (ERIVEDGE) filed by Genentech, Inc. The action expands the drug's labeling/indication for basal cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Erivedge (vismodegib)

Snippet

SUPPL AP for ERIVEDGE (VISMODEGIB)